Stocks and Investing Stocks and Investing
Tue, October 19, 2021

Matthew Harrison Downgraded (AKRO) to Hold and Held Target at $27 on, Oct 19th, 2021


Published on 2024-10-27 18:13:29 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Downgraded "Akero Therapeutics, Inc." (AKRO) to Hold and Held Target at $27 on, Oct 19th, 2021.

Matthew has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Aspen Mori of "B of A Securities" Initiated at Strong Buy and Held Target at $40 on, Friday, September 10th, 2021
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $64 on, Monday, August 16th, 2021

Contributing Sources